Patient no. | Sex | Aetiology of PH | Age yrs | P̄pa mmHg | PVR WU | Cardiac index L·min−1·m−2 | Prior specific PH therapy | PVR response ≥20% |
1# | Female | CHD | 62 | 42 | 5.6 | 2.4 | None | Yes |
2 | Male | CTEPH | 64 | 70 | 13.2 | 2 | None | No |
3# | Male | iPAH | 64 | 45 | 7.5 | 2.2 | Ilo | No |
4# | Female | iPAH | 62 | 63 | 17.2 | 1.9 | Ilo | No |
5¶ | Female | ILD | 59 | 47 | 5.2 | 3.7 | None | Yes |
6# | Male | iPAH | 71 | 49 | 13.8 | 1.53 | None | No |
7 | Female | iPAH | 36 | 54 | 10.7 | 2.34 | Ilo | No |
8 | Female | CTEPH | 56 | 60 | 12.5 | 2.15 | None | No |
9¶ | Female | ILD | 49 | 45 | 13.8 | 1.83 | None | No |
10¶ | Female | COPD | 53 | 34 | 4.6 | 3.21 | None | Yes |
11¶ | Female | ILD | 52 | 45 | 6.1 | 2.81 | None | No |
12¶ | Female | ILD | 58 | 44 | 12.0 | 1.65 | Ilo+Bos | No |
13¶ | Female | COPD | 63 | 27 | 3 | 2.34 | None | No |
14# | Male | iPAH | 71 | 47 | 9.8 | 2.05 | None | No |
15# | Male | iPAH | 43 | 35 | 5.6 | 3.03 | CCB+Ilo | Yes |
16 | Female | CTEPH | 59 | 28 | 4 | 3.01 | None | No |
17¶ | Female | COPD | 80 | 34 | 5.8 | 2.49 | None | Yes |
18# | Female | iPAH | 38 | 70 | 16.4 | 1.95 | CCB+Sil | No |
19# | Male | PAH | 68 | 27 | 9.6 | 1.25 | Sil | Yes |
20¶ | Female | ILD | 63 | 37 | 7.2 | 2.83 | Bos | No |